Skip to main content

2 Result(s)

within J. Romejko-Jarosińska Remove this filter

and

  1. No Access

    Article

    Rituximab (Mabthera™, rituxan™) in patients with recurrent indolent lymphoma

    The objective of this multiinstitutional study was to evaluate the safety and efficacy of rituximab at standard four weekly doses in patients with recurrent indolent lymphoma. Thirty-eight patients entered int...

    J. Walewski, E. Kraszewska, O. Mioduszewska, J. Romejko-Jarosińska… in Medical Oncology (2001)

  2. No Access

    Article

    CN3OP: an active regimen in patients with relapsed/refractory Hodgkin's lymphoma

    Patients with recurrent or refractory Hodgkin's and non-Hodgkin's lymphoma are increasingly being treated with high-dose therapy and hematopoietic cell transplantation. As minimal disease status at the time of...

    J Walewski, JB Krzyżanowska, E Kraszewska, E Lampka… in Medical Oncology (2000)